参考文献 References
[1] STEHLIKOVA Z, TLASKAL V, GALANOVA N, et al. Oral microbiota composition and antimicrobial antibody response in patients with recurrent aphthous stomatitis [J]. Microorganisms, 2019, 7(12): 636-649.
[2] HIJAZI K, MORRISON R W, MUKHOPADHYA I, et al. Oral bacterial diversity is inversely correlated with mucosal inflammation [J]. Oral Dis, 2020, 26(7): 1566-1575.
[3] MIN Z, YANG L, HU Y, HUANG R. Oral microbiota dysbiosis accelerates the development and onset of mucositis and oral ulcers [J]. Frontiers in microbiology, 2023, 14: 1061032.
[4] CONEJERO DEL MAZO R, GARCÍA FORCÉN L, NAVARRO AGUILAR M E. Recurrent aphthous stomatitis [J]. Med Clin (Barc), 2023, 161(6): 251-259.
[5] HIJAZI K, LOWE T, MEHARG C, et al. Mucosal microbiome in patients with recurrent aphthous stomatitis [J]. J Dent Res, 2015, 94(3 Suppl): 87s-94s.
[6] YANG Z, CUI Q, AN R, et al. Comparison of microbiomes in ulcerative and normal mucosa of recurrent aphthous stomatitis (RAS)-affected patients [J]. BMC Oral Health, 2020, 20(1): 128-135.
[7] OZDEMIR I Y, CALKA O, KARADAG A S, et al. Thyroid autoimmunity associated with recurrent aphthous stomatitis [J]. J Eur Acad Dermatol Venereol, 2012, 26(2): 226-230.
[8] THEODOROPOULOU K, VANONI F, HOFER M. Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome: a Review of the Pathogenesis [J]. Curr Rheumatol Rep, 2016, 18(4): 18-24.
[9] BARTAKOVA J, DEISSOVA T, SLEZAKOVA S, et al. Association of the angiotensin I converting enzyme (ACE) gene polymorphisms with recurrent aphthous stomatitis in the Czech population: case–control study [J]. BMC oral health, 2022, 22(1): 80-88.
[10] LU J, ZHANG N, WU C. LncRNA CASC 2 is upregulated in aphthous stomatitis and predicts the recurrence [J]. BMC Oral Health, 2020, 20(1): 12-16.
[11] ZHOU Y, WU J, WANG W, SUN M. Association between interleukin family gene polymorphisms and recurrent aphthous stomatitis risk [J]. Genes Immun, 2019, 20(1): 90-101.
[12] BANKVALL M, ÖSTMAN S, JONTELL M, TORINSSON NALUAI Å. A family-based genome-wide association study of recurrent aphthous stomatitis [J]. Oral Dis, 2020, 26(8): 1696-1705.
[13] AL-MAWERI S A, AL-QADHI G, HALBOUB E, et al. Vitamin D deficiency and risk of recurrent aphthous stomatitis: updated meta-analysis with trial sequential analysis [J]. Front Nutr, 2023, 10: 1132191.
[14] ZAKERI M, PARSIAN H, BIJANI A, et al. Serum levels of vitamin D in patients with recurrent aphthous stomatitis [J]. Dent Med Probl, 2021, 58(1): 27-30.
[15] AL-AMAD S H, HASAN H. Vitamin D and hematinic deficiencies in patients with recurrent aphthous stomatitis [J]. Clin Oral Investig, 2020, 24(7): 2427-2432.
[16] AYNALI G, OZKAN M, AYNALI A, et al. [The evaluation of serum vitamin B12, folic acid and hemoglobin levels in patients with recurrent minor aphthous stomatitis] [J]. Kulak Burun Bogaz Ihtis Derg, 2013, 23(3): 148-152.
[17] SUN A, CHEN H M, CHENG S J, et al. Significant association of deficiencies of hemoglobin, iron, vitamin B12, and folic acid and high homocysteine level with recurrent aphthous stomatitis [J]. J Oral Pathol Med, 2015, 44(4): 300-305.
[18] MA R, CHEN H, ZHOU T, et al. Effect of bedtime on recurrent aphthous stomatitis in college students [J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2015, 119(2): 196-201.
[19] KAMAT M, DATAR U, WADGAVE U, VARSHA V K. Association of bedtime with recurrent aphthous stomatitis: A cross-sectional study among health-care professional students [J]. J Oral Maxillofac Pathol, 2021, 25(3): 553-554.
[20] DU Q, NI S, FU Y, LIU S. Analysis of Dietary Related Factors of Recurrent Aphthous Stomatitis among College Students [J]. Evid Based Complement Alternat Med, 2018, 2018: 2907812.
[21] XU K, ZHOU C, HUANG F, et al. Relationship between dietary factors and recurrent aphthous stomatitis in China: a cross-sectional study [J]. J Int Med Res, 2021, 49(5): 1-13.
[22] ZHANG Y, WANG X, LI H, et al. Human oral microbiota and its modulation for oral health [J]. Biomedicine & Pharmacotherapy, 2018, 99: 883-893.
[23] WADE W G. The oral microbiome in health and disease [J]. Pharmacol Res, 2013, 69(1): 137-143.
[24] GHANNOUM M A, JUREVIC R J, MUKHERJEE P K, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals [J]. PLoS Pathog, 2010, 6(1): 1-8.
[25] PRIDE D T, SALZMAN J, HAYNES M, et al. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome [J]. Isme j, 2012, 6(5): 915-926.
[26] EDLUND A, SANTIAGO-RODRIGUEZ T M, BOEHM T K, PRIDE D T. Bacteriophage and their potential roles in the human oral cavity [J]. J Oral Microbiol, 2015, 7: 27423.
[27] EFENBERGER M, AGIER J, PAWŁOWSKA E, BRZEZIŃSKA-BŁASZCZYK E. Archaea prevalence in inflamed pulp tissues [J]. Cent Eur J Immunol, 2015, 40(2): 194-200.
[28] BELMOK A, DE CENA J A, KYAW C M, DAMÉ-TEIXEIRA N. The Oral Archaeome: A Scoping Review [J]. J Dent Res, 2020, 99(6): 630-643.
[29] FADHIL ALI MALAA S, ABD ALI ABD AUN JWAD B, KHALIS AL-MASOUDI H. Assessment of Entamoeba gingivalis and Trichomonas tenax in Patients with Chronic Diseases and its Correlation with Some Risk Factors [J]. Arch Razi Inst, 2022, 77(1): 87-93.
[30] ZAURA E, KEIJSER B J, HUSE S M, CRIELAARD W. Defining the healthy "core microbiome" of oral microbial communities [J]. BMC Microbiol, 2009, 9: 259.
[31] KANG J G, KIM S H, AHN T Y. Bacterial diversity in the human saliva from different ages [J]. J Microbiol, 2006, 44(5): 572-576.
[32] LI W, LIANG H, LIN X, et al. A catalog of bacterial reference genomes from cultivated human oral bacteria [J]. NPJ Biofilms Microbiomes, 2023, 9(1): 45-57.
[33] TANG Y L, SIM T S, TAN K S. Oral streptococci subvert the host innate immune response through hydrogen peroxide [J]. Sci Rep, 2022, 12(1): 656.
[34] LARSEN J M. The immune response to Prevotella bacteria in chronic inflammatory disease [J]. Immunology, 2017, 151(4): 363-374.
[35] ZHOU P, LI X, HUANG I H, QI F. Veillonella Catalase Protects the Growth of Fusobacterium nucleatum in Microaerophilic and Streptococcus gordonii-Resident Environments [J]. Appl Environ Microbiol, 2017, 83(19).
[36] LI Q, HU Y, ZHOU X, et al. Role of Oral Bacteria in the Development of Oral Squamous Cell Carcinoma [J]. Cancers (Basel), 2020, 12(10).
[37] SHEN X, ZHANG B, HU X, et al. Neisseria sicca and Corynebacterium matruchotii inhibited oral squamous cell carcinomas by regulating genome stability [J]. Bioengineered, 2022, 13(6): 14094-14106.
[38] ZARCO M F, VESS T J, GINSBURG G S. The oral microbiome in health and disease and the potential impact on personalized dental medicine [J]. Oral Dis, 2012, 18(2): 109-120.
[39] HUANG X, HUANG X, HUANG Y, et al. The oral microbiome in autoimmune diseases: friend or foe? [J]. J Transl Med, 2023, 21(1): 211.
[40] TU Y, XU X, ZHOU X D. [Development and Influencing Factors of Oral Microbiota in Early Life] [J]. Sichuan Da Xue Xue Bao Yi Xue Ban, 2022, 53(2): 220-225.
[41] SANTONOCITO S, GIUDICE A, POLIZZI A, et al. A Cross-Talk between Diet and the Oral Microbiome: Balance of Nutrition on Inflammation and Immune System's Response during Periodontitis [J]. Nutrients, 2022, 14(12).
[42] DECKER A M, KAPILA Y L, WANG H L. The psychobiological links between chronic stress-related diseases, periodontal/peri-implant diseases, and wound healing [J]. Periodontol 2000, 2021, 87(1): 94-106.
[43] YING K L, BRASKY T M, FREUDENHEIM J L, et al. Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking [J]. Cancer Prev Res (Phila), 2022, 15(7): 435-446.
[44] BACH L, RAM A, IJAZ U Z, et al. The Effects of Smoking on Human Pharynx Microbiota Composition and Stability [J]. Microbiol Spectr, 2023, 11(2): e0216621.
[45] CHENG X, HE F, SI M, et al. Effects of Antibiotic Use on Saliva Antibody Content and Oral Microbiota in Sprague Dawley Rats [J]. Front Cell Infect Microbiol, 2022, 12: 721691.
[46] CHEN B J, TAKESHITA T, TAJIKARA T, et al. Butyrate as a Potential Driver of a Dysbiotic Shift of the Tongue Microbiota [J]. mSphere, 2023, 8(1): e0049022.
[47] SU S C, CHANG L C, HUANG H D, et al. Oral microbial dysbiosis and its performance in predicting oral cancer [J]. Carcinogenesis, 2021, 42(1): 127-135.
[48] HARAN J P, BRADLEY E, ZEAMER A L, et al. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID [J]. JCI Insight, 2021, 6(20).
[49] CAI R, BI W, YU Y. Detection and Analysis of the Oral Flora in Patients with Recurrent Aphthous Stomatitis [J]. Evid Based Complement Alternat Med, 2022, 2022: 1705193.
[50] WANG X, LUO N, MI Q, et al. Influence of cigarette smoking on oral microbiota in patients with recurrent aphthous stomatitis [J]. J Investig Med, 2022, 70(3): 805-813.
[51] ZHU Z, HE Z, XIE G, et al. Altered oral microbiota composition associated with recurrent aphthous stomatitis in young females [J]. Medicine (Baltimore), 2021, 100(10): e24742.
[52] YUAN H, QIU J, ZHANG T, et al. Quantitative changes of Veillonella, Streptococcus, and Neisseria in the oral cavity of patients with recurrent aphthous stomatitis: A systematic review and meta-analysis [J]. Arch Oral Biol, 2021, 129: 105198.
[53] BANKVALL M, SJÖBERG F, GALE G, et al. The oral microbiota of patients with recurrent aphthous stomatitis [J]. J Oral Microbiol, 2014, 6: 25739.
[54] KIM Y J, CHOI Y S, BAEK K J, et al. Mucosal and salivary microbiota associated with recurrent aphthous stomatitis [J]. BMC Microbiol, 2016, 16 Suppl 1: 57.
[55] GASMI BENAHMED A, NOOR S, MENZEL A, GASMI A. Oral Aphthous: Pathophysiology, Clinical Aspects and Medical Treatment [J]. Arch Razi Inst, 2021, 76(5): 1155-1163.